NS
Nagasai Srikesh Vankadara
About Nagasai Srikesh Vankadara
Data last updated:
Nagasai Srikesh Vankadara is a Director at Vakcad Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals. Vakcad Pharmaceuticals Private Limited reported revenue of ₹28.7 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vakcad Pharmaceuticals Private Limited U24240HP2022PTC009172 | Director | 02 Mar 2022 | 2022 | ₹28.7 Lakh (FY 2024) | Active |
Board colleagues of Nagasai Srikesh Vankadara
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vankadara Padmanabhaiah | 03409806 | Vakcad Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nagasai Srikesh Vankadara
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nagasai Srikesh Vankadara
Nagasai Srikesh Vankadara currently holds 1 directorship: Vakcad Pharmaceuticals Private Limited (Director, since 02 Mar 2022, revenue ₹28.7 Lakh (FY 2024)).
Nagasai Srikesh Vankadara was first appointed on 02 Mar 2022 as Director at Vakcad Pharmaceuticals Private Limited.
The current boards of Nagasai Srikesh Vankadara's companies include Vankadara Padmanabhaiah (Vakcad Pharmaceuticals Private Limited).